CJC-1295 (no DAC) is a synthetic analog of growth hormone–releasing hormone (GHRH), modified to resist enzymatic degradation. Unlike the original CJC-1295, this version excludes the Drug Affinity Complex (DAC), giving it a short half-life more representative of endogenous GHRH signaling — a distinction that matters for researchers modeling natural GH pulse dynamics rather than sustained elevation.
It's frequently used in research alongside GH secretagogues such as Ipamorelin, allowing investigators to study the combined effect of GHRH and ghrelin-receptor pathways on the somatotropic axis in vitro and in animal models.
This product is intended strictly for laboratory research use. It is not a drug, dietary supplement, or food product, and is not evaluated or approved by the FDA for any use in humans or animals. It is not for human consumption.
Every lot is tested by an independent, accredited lab before it's listed — purity, heavy metals, endotoxins, and quantity — with the full Certificate of Analysis published and traceable to that specific lot.
[Identity confirmed on certificate]